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Abstract
Background: The thymus arises in the ventral portion of the third and fourth pharyngeal pouch. It descends into the 
anterior mediastinum at 6th week of gestation. Any errors occurring during this process can cause dissemination of 
aberrant nodules that are responsible for most atypical thymomas.
Case Presentation: The authors report a unusual case of type-A thymoma located in D10 and D11 vertebral bodies.
The histology showed a uniform growth of short, spindle shaped, mitotically inactive cells. A few small, normal
lymphocytes were seen scattered or in small groups. The immunohistochemical investigation for neuroectodermal,
neuroendocrine, vascular and muscular markers were negative. It also confirmed the presence of CD3+, CD5+ T
lymphocytes and the absence of immature T-lymphocyte markers.
Conclusions: The case described shows a thymic hystogenesis for spindle cell tumours. To our knowledge no other 
cases of vertebral thymomas have been described in international literature.
Backgroud
The thymus arises in the ventral portion of the third and
fourth pharyngeal pouch. It descends into the anterior
mediastinum at 6th week of gestation. Any errors occur-
ring during this phase can cause dissemination of aber-
rant nodules that are responsible for most uncommon
thymomas [1]. Seldomly do thymomas appear in other
locations, such as the base of the skull [2], pulmonary
parenchyma [3], pleura [4], and in the middle mediasti-
num [5]. We describe here the first case of intra-vertebral
type-A thymoma where a thorough immunohistochemi-
cal assessment has been carried out.
Case Presentation
A 59-year-old woman presenting with a tumour mass
located in D11 with partial invasion of D10 causing mid-
dle back pain one year before.
There was no family history of bone lesions or bone
tumours. There were no general symptoms, such as an
increase in temperature or loss of weight or appetite.
Clinical examination results showed localized pain
increasing with compression. A systemic examination
was performed and tested negative. Laboratory studies
were not helpful. X-rays revealed an osteolytic lesion
eroding the anterior cortex, the superior endplate involv-
ing the upper vertebra (fig. 1). The CT-scan and MRI (fig.
2) confirmed the subtotal substitution of the vertebral
body. A CT-scan performed about one year before con-
firmed similar results. The bone scan indicated a slight
increase in local uptake and no sign of bone metastasis,
the condition was confirmed by a total-body CT-SCAN.
While X-rays and CT-scans of the chest were normal.
The mass was angiographically quite avascular suggest-
ing a low grade lesion, according to the FDG-PET which
demonstrated low metabolic activity and no signs of dis-
semination. As a tumour was suspected a CT-guided nee-
dle-biopsy was performed under local anesthesia through
the left pedicle.
Histopathological tests showed a mitotically inactive
spindle cell tumour, however, no definite diagnosis could
be performed as material was scant and the immunohis-
tochemical findings were inconsistent.
Hemangiopericytoma and paraganglioma were
excluded because of low vascular grade; a metastasis
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Page 2 of 5from renal carcinoma, before hypothesized was excluded
because contrasted with angiography and FDG-PER-
FDG pattern. Having an uncertain diagnosis, a tumour
mass has to be treated as a primitive tumour with thera-
peutic intent thus an en-block vertebral resection was
proposed. The patient was informed about the high sur-
gical and post-surgical risks and would not accept under-
going the procedure, so therefore a less dangerous
palliative surgical procedure was chosen. During the first
surgical operation a laminectomy and a posterior stabili-
zation were performed without carrying out a biopsy, so
that the tumour would not spread to the posterior access.
Curettage and stabilization with a titanium cage,
cement and anterior plate was performed about two
months later by intercostals-lateral approach.
Postoperative inpatient time followed without any
problems and the patient was discharged after ten days in
order to start rehabilitation.
Histopathological features were done on the curetted
material, and pin-pointed the localization of ectopic thy-
momas so that a meticulous immunohistochemical test
panel was applied to confirm the hypothesis.
An indirect immunoperoxidase staining was performed
on 2 μm formalin fixed paraffin embedded sections by a
streptavidin-biotin enhanced immunoperoxidase tech-
nique (Super Sensitive MultiLink, Novocastra, Menarini
Florence, Italy) in an automated auto-stainer (Bond Max ,
Menarini) using monoclonal and polyclonal antibodies
directed to the following antigens: CD99 (clone MIC2,
UCS Diagn. Rome, Italy), chromogranin A (clone DAK-
A3, Dako, Milan, Italy), Smooth Muscle Actin (clone 1A4,
Dako) without any retrieval pre-treatments, HMB45
(clone HMB45 Dako), Synaptophysin (clone SY38, Dako),
CD31 (clone JC/70A, Dako), CD34 (clone QBEND,
Novocastra, Menarini, Florence, Italy), pan-cytokeratin
(clone AE1/AE3, Novocastra), keratin 19 (clone RCK108,
Dako), keratin 7 (clone OVTL12/30, Dako), Vimentin
(clone V9, Dako), CD56 (clone BC56C04, UCS), EMA
(clone E-29, Dako), Bcl2 (clone 124, Dako), CD20 (clone
L26, Menarini), CD1a (clone 010, Dako), CD68 (clone
KP1, Dako) after pre-treatment of the sections in a ther-
mostatic bath at 96° C for 40 min in a pH 6 citrate buffer,
CD5 (clone 4C7, Menarini) after pre-treatment of the
sections in a thermostatic bath at 96° C for 40 min in a pH
8 EDTA buffer, S100 (polyclonal, Menarini), Calponin
(polyclonal, UCS), pan-cytokeratin (MNF116, Dako), ker-
atin 8 (35βH11, Dako), collagen IV (CIV94, Zymed, His-
toline, Milan, Italy) after enzymatic pre-treatment.
Diaminobenzidine (Menarini) was used as chromogenic
substrate.
Pathology description
Under microscope, the tumour showed a uniform growth
of short, spindle shaped, mitotically inactive cells. A few
small, typical lymphocytes were seen scattered or in small
groups (fig. 3).
An hemangiopericytic pattern was formed by the short,
spindle-shaped cells with bland vesicular fused nuclei. In
some areas a gap was found between the epithelial sheets
and the tiny-walled vessels.
The immunohistochemical investigations tested nega-
tive for neuroectodermal (CD99, S100, HMB45), neu-
roendocrine (Chromogranin, Synaptophysin), vascular
(CD31, CD34) and muscular (Calponin) markers,
whereas the spindle cells were consistently positive for
Figure 1 Chest CT of lesion. Chest CT showing osteolytic lesion of 
D11 eroding anterior cortex and superior endplate and involving supe-
rior vertebral body.
Figure 2 MRI of lesion. T2-weighted MRI image showing the tumour 
in D11 involving the upper vertebra as well.
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19 and cytokeratin 7 (fig. 4).
Furthermore, vimentin, epithelial membrane antigen
(EMA), CD56, cytokeratin 8, BCL2 (week), were focally
positive. The staining for CD20 showed an extensive
multi-focal positive membranous staining of the spindle
epithelial cells (fig. 5). The small lymphocytes were
mature T lymphocytes CD3+, CD5+, negative for the
immature T- lymphocyte markers CD1a, CD10, CD99.
The staining for collagen IV showed strong intercellular
deposition of the collagen among ribbons and nests of
spindle cells (fig. 6). Varying from the tumour cells, scat-
tered accessory cells were found to be positive for smooth
muscle actin, S100, CD1a and CD68.
Cytogenetic analysis
A search of the SYT translocation t(X;18)(p11;q11)
(WHO 2002) as typical for synovial sarcoma, performed
by fluorescent In situ hybridization (FISH) with the vysis
probe of inter-phase nuclei in formalin-fixed, paraffin
embedded sections showing negative results.
Conclusions
In the posterior mediastinum, a variety of tumours occur,
however the majority of them are of neurogenic origin,
schwannomas and neurofibromas being the most fre-
quently encountered neoplasms [6]. In our case, the para-
vertebral site and the absence of clinical evidence for a
metastatic spread suggested a localization of a primary
tumour. Several entities were considered in the differen-
tial diagnosis, while no definite clinical, morphological
and immunohistochemical character of diagnostic rele-
Figure 4 Immunohistology for Cytokeratin. Immunohistology 
showing positivity for Cytokeratin cocktails MNF116 20× magnifica-
tion.
Figure 5 Immunohistology for CD20. Immunohistology showing 
positivity for CD20 20X magnification
Figure 6 Immunohistology for collagen IV. Immunohistology 
showing positivity with a strong intercellular deposition of collagen IV 
20× magnification
Figure 3 Histopathology. Histopathology showing a uniform 
growth of short, spindle shaped, mitotically inactive cells. Few small, 
typical lymphocytes were observed scattered or in small groups (He-
matoxylin-Eosin stain, 20× magnification)
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ity of a neurogenic origin was excluded because of the
absence of a rich angiographic pattern and the neuroec-
todermal marker considered (S100).
The diagnosis of hemangiopericytoma was excluded
because there were no typical spider-like radial branching
vessels nor collagen IV and CD99 positivity.
A melanoma metastasis was excluded due to the bland
cytological appearance, the lack of mitotic activity and
the S100 and HMB45 negativity. Similarly, the possibility
of a solitary fibrous tumour was ruled out on the basis of
the CD34 negativity and of the week positivity [7] of bcl2.
The hypothesis that the lesion might have been a renal
carcinoma metastasis, which appeared after the first sur-
gery, was highly unlikely both from an angiographical
aspect and the metabolic activity showed by FDG-PET.
The diagnosis of Chordoma was excluded basing on
FDG-PET activity as well as plasmocitoma that should
have had no hyperfissation period in bone scan and high
activity in FDG-PET.
In this case, the possibility of a synovial sarcoma was
ruled out not only by the bland appearance of the nuclei,
but by the lack of mitotic activity and the absence of the
SYT translocation typically associated to Synovial sar-
coma, as demonstrated by the FISH investigation.
In our case, the widespread positivity for Cytokeratins
is in keeping only with epithelial tumours. Thymic epi-
thelial tumours occur in several ectopic sites, such as
inside or outside (particularly in cervical location) the
thoracic cavity, according to the embryological derivation
of the thymus from the IV branchial cleft. In the posterior
mediastinum, the occurrence of ectopic thymoma has
rarely been reported, but nevertheless the para-vertebral
site has to be considered as a possible site for ectopic thy-
momas emerging. Nevertheless, in our case the lesion is
clearly located in vertebral body and not in the posterior
mediastinum, furthermore the bland appearance of the
fusiform nuclei, the presence of scattered typical lympho-
cytes, the presence of peri-vascular spaces as typical for
thymic epithelial tumours (TET), the strong collagen IV
deposits among the spindle cells and the extensive co-
expression of cytokeratins and CD20 were considered
highly diagnostic for type A thymoma according to the
World Class Organization classification system of TET
[8]. The hemangiopericytic pattern is a frequent feature
in spindle cell (type A) thymoma. Furthermore, the diag-
nostic value of the co-expression of cytokeratins and
CD20 was considered. CD20 (L26), i.e. a fundamental
marker of B-lymphocytes, was described as a frequent
and specific marker of the medullary type of thymoma
[9]. More recently, the frequency of the CD20 staining in
spindle (medullary, WHO type A) and mixed spindle/
lymphocytic (WHO type AB) thymoma has also been
described as a specific feature of such thymoma types
[10,11]. The presence of immature T lymphocytes is usu-
ally considered a feature related to the thymic origin of an
epithelial tumour both inside and outside the thorax.
However, the spindle cell, medullary (type A) thymomas
are devoid of thymopoietic activity and the associated
lymphoid component reflects the mature appearance and
the mature T-cell phenotype belonging to the thymic
medulla [12]. Type A and AB thymoma are usually char-
acterized by a low grade of malignancy.
Established the thymic tissue origin of the lesion the
metastatic nature was the most probable nevertheless it
was excluded and the tumour considered primary
because both FDG-PET and total body CT-SCAN didn't
detect other lesions or ectopic thymus. The hypothesis is
today confirmed by the checks performed at two years of
follow-up.
The long history of the present case reflects this general
tendency, although a local invasive capacity has been well
documented. Furthermore, the case described points
considering thymic origins for spindle cell tumours with a
hemangiopericytic pattern of unknown derivation.
Considering the low grade of malignancy, the treatment
chosen by the patient was acceptable for her disease.
However an en-block vertebral resection would have
decreased the risk of recurrence. A further treatment as
radiation therapy was temporary excluded; the possibility
to perform a second surgery and then radiation therapy
was considered preferable according to the patient. In
order to guarantee a correct histopathological interpreta-
tion as well as treatment, diagnosis has to be done based
on patient history and clinical imaging.
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